| Q34343584 | A rapid method of detecting autoantibody against FcεRIα for chronic spontaneous urticaria |
| Q35961702 | ASSURE-CSU: a real-world study of burden of disease in patients with symptomatic chronic spontaneous urticaria |
| Q35658142 | Activation of Blood Coagulation in Two Prototypic Autoimmune Skin Diseases: A Possible Link with Thrombotic Risk |
| Q47735699 | Application value of laboratory indexes in the differential diagnosis of Henoch-Schoenlein purpura |
| Q51575083 | Basophil CD63 expression in chronic spontaneous urticaria: correlation with allergic sensitization, serum autoreactivity and basophil reactivity. |
| Q42736757 | Chronic Spontaneous Urticaria: Pathogenesis and Treatment Considerations |
| Q90398003 | Chronic Spontaneous Urticaria: The Devil's Itch |
| Q90380732 | Chronic urticaria and thyroid pathology |
| Q38907508 | Chronic urticaria in the real-life clinical practice setting in Sweden, Norway and Denmark: baseline results from the non-interventional multicentre AWARE study. |
| Q40989403 | Chronic urticaria: a focus on pathogenesis |
| Q91688043 | Coagulation and Skin Autoimmunity |
| Q39596378 | Cold urticaria: a 20-year follow-up study |
| Q47783261 | Disease-specific impairment of the quality of life in adult patients with chronic spontaneous urticaria |
| Q92579009 | Emerging Therapies in Chronic Spontaneous Urticaria |
| Q38693457 | Epidemiology of Chronic Urticaria in Korea Using the Korean Health Insurance Database, 2010-2014. |
| Q40001317 | Epidemiology of chronic spontaneous urticaria: results from a nationwide, population-based study in Italy |
| Q92164928 | High-dose levocetirizine for the treatment of refractory chronic spontaneous urticaria and the effect on the serum inositol triphosphate level |
| Q38771632 | Looking forward to new targeted treatments for chronic spontaneous urticaria |
| Q41103892 | Management of chronic spontaneous urticaria in the elderly |
| Q39012896 | Mechanisms of action that contribute to efficacy of omalizumab in chronic spontaneous urticaria |
| Q38310407 | Omalizumab for the treatment of chronic urticaria |
| Q34794295 | Omalizumab vs. placebo in the management of chronic idiopathic urticaria: a systematic review |
| Q38239664 | Pathogenesis of chronic urticaria: an overview |
| Q34459030 | Placebo effects on itch: a meta-analysis of clinical trials of patients with dermatological conditions |
| Q36465514 | Prognostic Factors for Chronic Spontaneous Urticaria: A 6-Month Prospective Observational Study. |
| Q92503018 | Refractory chronic spontaneous urticaria after the use of alemtuzumab in multiple sclerosis |
| Q35930834 | Resource use and costs in an insured population of patients with chronic idiopathic/spontaneous urticaria |
| Q93050441 | Sleep quality among adult patients with chronic dermatoses |
| Q35478921 | Suppression of basophil FcɛRI activation by serum from active chronic idiopathic/spontaneous urticaria (CIU/CSU) subjects |
| Q59793790 | The overlap syndrome of urticaria and gastroesophageal reflux disease |
| Q38276193 | Treatment of severely recalcitrant chronic spontaneous urticaria: a discussion of relevant issues |